Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein
syntaxin 1A
(SYN1A) interacts with and regulates the function of transmembrane proteins, including ion channels and neurotransmitter transporters. Here, we define the first 33 amino acids of the N terminus of the dopamine (DA) transporter (
DAT
) as the site of direct interaction with SYN1A. Amphetamine (AMPH) increases the association of SYN1A with human
DAT
(hDAT) in a heterologous expression system (hDAT cells) and with native
DAT
in murine striatal synaptosomes. Immunoprecipitation of
DAT
from the biotinylated fraction shows that the AMPH-induced increase in
DAT
/SYN1A association occurs at the plasma membrane. In a superfusion assay of DA efflux, cells overexpressing SYN1A exhibited significantly greater AMPH-induced DA release with respect to control cells. By combining the patch-clamp technique with amperometry, we measured DA release under voltage clamp. At -60 mV, a physiological resting potential, AMPH did not induce DA efflux in hDAT cells and DA neurons. In contrast, perfusion of exogenous SYN1A (3 microM) into the cell with the whole-cell pipette enabled AMPH-induced DA efflux at -60 mV in both hDAT cells and DA neurons. It has been shown recently that Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated by AMPH and regulates AMPH-induced DA efflux. Here, we show that AMPH-induced association between
DAT
and SYN1A requires CaMKII activity and that inhibition of CaMKII blocks the ability of exogenous SYN1A to promote DA efflux. These data suggest that AMPH activation of CaMKII supports
DAT
/SYN1A association, resulting in a mode of
DAT
capable of DA efflux.
...
PMID:Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. 1861 32
The Caenorhabditis elegans (C. elegans) dopamine (DA) transporter (
DAT
-1) regulates DA signaling through efficient DA reuptake following synaptic release. In addition to its DA transport function,
DAT
-1 generates detectable DA-gated currents that may influence neuronal excitability. Previously, we provided evidence that single Cl-channel events underlie
DAT
-1 currents. In these studies, we identified a distinct population of altered
DAT
-1 currents arising from
DAT
-1 transgenic constructs bearing an N-terminal GFP fusion. The presence of these channels suggested disruption of an endogenous regulatory mechanism that modulates occupancy of
DAT
-1 channel states. A leading candidate for such a regulator is the SNARE protein
syntaxin 1A
(Syn1A), previously found to interact with homologous transporters through N-terminal interactions. Here we establish that UNC-64 (C. elegans Syn1A homologue) associates with
DAT
-1 and suppresses transporter channel properties. In contrast, GFP::
DAT
-1 is unable to form stable transporter/UNC-64 complexes that limit channel states. Although
DAT
-1 and GFP::
DAT
-1 expressing DA neurons exhibit comparable DA uptake, GFP::
DAT
-1 animals exhibit swimming-induced paralysis (SWIP), a phenotype associated with excess synaptic DA release and spillover. We propose that loss of UNC-64/
DAT
-1 interactions leads to enhanced synaptic DA release, providing a novel mechanism for DA neuron sensitization that may be relevant to mechanisms of DA-associated disorders.
...
PMID:Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. 1876 15